Impact of Systematic EGFR and KRAS Mutation Evaluation on Progression-Free Survival and Overall Survival in Patients with Advanced Non–Small-Cell Lung Cancer Treated by Erlotinib in a French…

Overview of attention for article published in Journal of Thoracic Oncology, October 2012

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 67 Dimensions

Readers on

mendeley: 77 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 4,988 followers.

Current ToC: Impact of Systematic EGFR and KRAS Mutation Evaluation on Progression-Free Survival and Overall Sur... http://t.co/enYrCiPW

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.